77 related articles for article (PubMed ID: 2914408)
21. The effects of vitamin C supplementation on biomarkers of oxygen radical generated damage in human volunteers with "low" or "high" cholesterol levels.
Anderson D; Phillips BJ; Yu TW; Edwards AJ; Ayesh R; Butterworth KR
Environ Mol Mutagen; 1997; 30(2):161-74. PubMed ID: 9329641
[TBL] [Abstract][Full Text] [Related]
22. Fuzzy role of hyperhomocysteinemia in hemodialysis patients' mortality.
Simic-Ogrizovic S; Stosovic M; Novakovic I; Pejanovic S; Jemcov T; Radovic M; Djukanovic L
Biomed Pharmacother; 2006 May; 60(4):200-7. PubMed ID: 16647238
[TBL] [Abstract][Full Text] [Related]
23. Oxalic Acid as a uremic toxin.
Mydlík M; Derzsiová K
J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
[TBL] [Abstract][Full Text] [Related]
24. [Influence of early or late referral to nephrologist over morbidity and mortality in hemodialysis].
Gallego E; López A; Lorenzo I; López E; Llamas F; Illescas ML; Andrés E; Serrano A; Olivas E; Gómez Roldán C
Nefrologia; 2003; 23(3):234-42. PubMed ID: 12891938
[TBL] [Abstract][Full Text] [Related]
25. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker.
Washio K; Inagaki M; Tsuji M; Morio Y; Akiyama S; Gotoh H; Gotoh T; Gotoh Y; Oguchi K
Nephron Clin Pract; 2008; 109(2):c49-54. PubMed ID: 18544955
[TBL] [Abstract][Full Text] [Related]
26. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.
St Peter WL; Li S; Liu J; Gilbertson DT; Arneson TJ; Collins AJ
Pharmacotherapy; 2009 Feb; 29(2):154-64. PubMed ID: 19170585
[TBL] [Abstract][Full Text] [Related]
27. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
[TBL] [Abstract][Full Text] [Related]
28. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
29. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
30. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
[TBL] [Abstract][Full Text] [Related]
31. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
32. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
33. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
[TBL] [Abstract][Full Text] [Related]
34. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.
Korevaar JC; van Manen JG; Dekker FW; de Waart DR; Boeschoten EW; Krediet RT;
J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945
[TBL] [Abstract][Full Text] [Related]
35. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients.
Fumeron C; Nguyen-Khoa T; Saltiel C; Kebede M; Buisson C; Drüeke TB; Lacour B; Massy ZA
Nephrol Dial Transplant; 2005 Sep; 20(9):1874-9. PubMed ID: 15972322
[TBL] [Abstract][Full Text] [Related]
36. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
[TBL] [Abstract][Full Text] [Related]
37. Should vitamin C supplementation be restricted in regular hemodialysis patients?
Ono K; Hisasue Y; Morimatsu M
ASAIO Trans; 1986; 32(1):111-3. PubMed ID: 3535840
[No Abstract] [Full Text] [Related]
38. Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients.
Pru C; Eaton J; Kjellstrand C
Nephron; 1985; 39(2):112-6. PubMed ID: 3974772
[TBL] [Abstract][Full Text] [Related]
39. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
40. Plasma vitamin C concentrations in patients on routine hemodialysis and its relationship to patients' morbidity and mortality.
Dashti-Khavidaki S; Talasaz AH; Tabeefar H; Hajimahmoodi M; Moghaddam G; Khalili H; Lessan-Pezeshki M; Jahanmardi A
Int J Vitam Nutr Res; 2011 Jul; 81(4):197-203. PubMed ID: 22237767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
